190 related articles for article (PubMed ID: 2886491)
1. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.
Harsch HH
J Clin Psychiatry; 1987 Aug; 48(8):328-33. PubMed ID: 2886491
[TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology and therapy of malignant neuroleptic syndrome].
Weller M; Kornhuber J
Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662
[TBL] [Abstract][Full Text] [Related]
3. [Neuroleptic malignant syndrome].
Sczesni B; Schröder J; Becker H; Przuntek H
Wien Klin Wochenschr; 1991; 103(1):1-7. PubMed ID: 1673041
[TBL] [Abstract][Full Text] [Related]
4. The neuroleptic malignant syndrome.
Smego RA; Durack DT
Arch Intern Med; 1982 Jun; 142(6):1183-5. PubMed ID: 6124221
[TBL] [Abstract][Full Text] [Related]
5. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome: a review and report of six cases.
Kasantikul D; Kanchanatawan B
J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome: a review of the literature.
Pearlman CA
J Clin Psychopharmacol; 1986 Oct; 6(5):257-73. PubMed ID: 2877012
[TBL] [Abstract][Full Text] [Related]
8. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
[TBL] [Abstract][Full Text] [Related]
9. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
10. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome: a case report.
Fekadu A; Wakwoya A
Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome.
McHugh TP
J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
[TBL] [Abstract][Full Text] [Related]
13. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
Lee JW
Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
Freedman MD
Md Med J; 1997 Aug; 46(7):357-9. PubMed ID: 9260471
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM; Shifrar KA
Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
[TBL] [Abstract][Full Text] [Related]
16. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
Andreassen MD; Pedersen S
Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
[TBL] [Abstract][Full Text] [Related]
17. [Neuroleptic malignant syndrome].
Murak E
Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
[TBL] [Abstract][Full Text] [Related]
18. All elevated creatine kinase is not neuroleptic malignant syndrome.
Maniam T; Rahman MA
Med J Malaysia; 1994 Sep; 49(3):252-4. PubMed ID: 7845275
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome: long-term follow-up of 20 cases.
Pope HG; Aizley HG; Keck PE; McElroy SL
J Clin Psychiatry; 1991 May; 52(5):208-12. PubMed ID: 1674508
[TBL] [Abstract][Full Text] [Related]
20. Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.
de Mari M; Lamberti P; Simone F; Iliceto G; Federico F; Ferrari E
Funct Neurol; 1991; 6(3):285-8. PubMed ID: 1683852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
